Table 2 Clinical outcomes after rebleeding in patients with small bowel angioectasia
From: Frequency and risk factors for rebleeding events in patients with small bowel angioectasia
| Â | Patients with rebleeding |
|---|---|
Number | 23 |
Bleeding pattern (overt/occult) | 12/11 |
Blood transfusion, number (%) | 11 (47.8) |
Minimum hemoglobin value after rebleeding, g/dl | 9.1 ± 2.4 |
Endoscopic treatment, number (%) | 8 (34.8) |
Controlled by the end of the follow-up period*, number (%) | 18 (78.3) |
Iron replacement therapy after rebleeding, number (%) | 23 (100) |
Hemoglobin value at the end of the follow-up period, g/dl | 11.4 ± 2.1 |